• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

FDC Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 14482.0
  • ISIN : INE258B01022
393.95 -1 (-0.24%)
  • As on 29 Mar 2025 (EOD)
  • Today’s Low

    389.10
  • Today’s High

    403.40
  • Open

    399.00
  • Perv Close

    394.90
  • 52W Low

    366.25
  • 52W High

    658.85

Key Indicators

  • P/E(TTM)

    23.46

  • Mar.Cap (₹Cr.)

    6,413.90

  • Div & Yield %

    0.00

  • Book Value(₹)

    140.44

  • Debt-Equity Ratio

    -0.24

  • AGM Date

    28-Mar-2025

  • EPS

    16.81

  • P/E Ratio

    23.46

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    6,413.90

  • RONW (%)

    14.96

  • ROCE (%)

    19.17

Score Board

  • Equity (₹ in Cr.)

    16.28

  • BV (₹)

    140.40

  • Sales( ₹ in Cr.)

    1,916.19

  • NP (in Cr.)

    290.89

  • NP Var(%)

    48.0

  • Div%

    0.0

  • CPS (₹)

    20.30

  • EPS (₹)

    17.90

  • Traded Value (₹ in Lakhs)

    6,419.60

  • 52 Week High

    658.85

  • 52 Week Low

    366.25

  • Price BSE

    394.0

  • Price NSE

    394.00

  • Market Capital( in Cr.)

    6,419.60

  • P/C Ratio

    19.40

  • P/E Ratio

    22.10

  • Price Vs.BV

    17.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,916.19 1,777.03 1,518.97 1,325.45 1,331.09 1,075.87
Excise Duty 1,908.46 1,771.24 1,514.71 1,315.58 1,322.64 1,067.68
Net Sales 1,916.19 1,777.03 1,518.97 1,325.45 1,331.09 1,075.87
Other Income 103.22 53.91 78.73 97.15 82.66 54.80
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 2,019.40 1,830.94 1,597.70 1,422.60 1,413.75 1,130.67
EXPENDITURE :
Raw Materials 1,908.46 1,771.24 1,514.71 1,315.58 1,322.64 1,067.68
Power & Fuel Cost 1,908.46 1,771.24 1,514.71 1,315.58 1,322.64 1,067.68
Employee Cost 408.99 386.99 339.97 294.31 276.18 226.19
Other Manufacturing Expenses 29.68 24.18 30.36 26.99 76.66 42.06
Selling & Administrative Expenses 304.08 285.28 232.70 155.89 159.55 137.50
Miscellaneous Expenses 29.68 24.18 30.36 26.99 76.66 42.06
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,621.46 1,565.25 1,312.25 1,042.14 1,088.29 890.40
Operating Profit 189.17 171.74 141.24 111.88 110.59 105.59
Interest 4.00 4.04 3.05 3.40 3.41 1.43
Gross Profit 397.95 265.69 285.45 380.45 325.46 236.30
Depreciation 39.73 38.76 37.08 37.62 37.36 33.14
Profit Before Tax 397.95 265.69 285.45 380.45 325.46 236.30
Tax 87.60 69.00 68.00 84.52 82.80 66.60
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.16 -4.28 -2.18 1.44 -4.12 -1.84
Reported Net Profit 307.16 200.97 219.64 294.49 246.78 171.54
Extraordinary Items 397.95 265.69 285.45 380.45 325.46 236.30
Adjusted Net Profit 307.16 200.97 219.64 294.49 246.78 171.54
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 13.68 0.00
P & L Balance carried down 307.16 200.97 219.64 294.49 246.78 171.54
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 80.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.80 0.00
Earnings Per Share-Unit Curr 18.70 12.09 13.01 17.32 14.34 9.84
Book Value 0.00 0.00 0.00 0.00 13.68 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 13.68 0.00

Shareholding Pattern

  • Promoter Group

    69.66%

  • Public Share Holding

    30.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 24,891,913 15.29 24,891,913 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 88,518,520 54.37 88,518,520 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 113,410,433 69.66 113,410,433 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,344,558 2.67 4,344,558 100
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 111,898 0.07 111,898 2
Mutual Funds / UTI 9,551,110 5.87 9,551,110 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 236,664 0.15 236,664 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 14,244,230 8.75 14,244,230 116
2] Non Institution
Bodies Corporate 4,078,081 2.50 4,078,081 446
Clearing Members 257 0.00 257 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,649,318 1.63 2,649,318 1,721
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 970,129 0.60 969,129 1,432
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,257,062 4.46 7,249,062 14
Individuals holding nominal share capital up to Rs. 1 lakh 19,725,505 12.12 18,508,782 51,450
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,501 0.00 4,501 2
Others 355,452 0.22 355,452 1
Sub Total 35,155,421 21.59 33,929,698 55,104
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 162,810,084 100.00 161,584,361 55,228

Company Background

FDC LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • FDC Ltd
  • BSE Code : 14482.0
  • ISIN : INE258B01022
  • Incorporation Year

    1940

  • Registered Office

    B-8 MIDC Industrial Area
    Waluj Dist, Aurangabad (Maharashtra),
    Maharashtra-431136

  • Telephone

    91-240-2554407/967/299

  • FAX

    91-240-2554299

  • Chairman

    Uday Kumar Gurkar

  • Managing Director

    Mohan A Chandavarkar

  • Company Secretary

    Varsharani Katre

  • Auditor

    B S R & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    Unit No 1 Luthra Ind,
    Andheri Kurla Road ,Safed Pool Andheri(E
    Mumbai - Mumbai - 400 072

FDC Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
FDC 394.30 2,019.40 1,916.19 23.46 19.26
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92